CBD is a CB1 antagonist having a weak affinity for the CB1 receptor, which means it doesn’t bind really strongly. The risk of progressing from managed usage of psychoactive drugs to compulsive and uncontrolled drug-use behaviors that characterize dependancy is especially substantial in people who have pre- and/or co-morbid pathology, https://devingtbnr.bloggip.com/32952483/everything-about-cannabis